Medtronic – Vein Therapy News

MEDTRONIC FOUNDATION GIVES $10 MILLION MORE TO COVID-19 EFFORTS

The Medtronic Foundation is making an additional $10 million in contributions to COVID-19 relief efforts around the world. The Fridley, Minn.-based company spokesman said that the funds will be put toward training and supervising frontline health workers, ensuring their…

February182020October252024

GEOFF MARTHA TO REPLACE OMAR ISHRAK AT MEDTRONIC APRIL 27

Geoff Martha, who leads Medtronic’s restorative therapies group and previously oversaw the company’s spine business, will succeed Omar Ishrak as president and CEO on April 27. Ishrak ‘s nearly 10-year tenure as chairman and CEO of Medtronic…

February122020

MEDTRONIC AND THE MEDTRONIC FOUNDATION COMMIT MORE THAN $1M TO CORONAVIRUS EFFORTS

Medtronic plc and the Medtronic Foundation are committing approximately $1.2 million to coronavirus relief efforts across the globe. These contributions encompass Medtronic Foundation cash contributions and product donations from the company, according to an announcement Feb. 10. …

June262019October252024

CHARING CROSS 2019: MEDTRONIC EXPANDS ON KEY AORTIC SOLUTIONS FOR CHALLENGING ANATOMIES

Medtronic plc released new data on endovascular repair of abdominal aortic aneurysm (AAA) patients with the Endurant II/IIs stent graft system in combination with Heli-FX EndoAnchor implants and for the Valiant Navion thoracic stent graft system for thoracic endovascular repair…

June122019October252024

VECLOSE EXTENSION STUDY: Five-year outcomes prove durability, safety, efficacy of VenaSeal Closure System

By Larry Storer Five-year results from the 2019 VeClose Extension Study of the Medtronic VenaSeal Closure System demonstrate that the treatment modality is consistent, durable and safe for permanently closing veins in patients with venous reflux disease. When…

Government policy shift prompts Medtronic to bail on bundled knees; Responsive Orthopedics for sale

After three years in the bundled joint replacement business, a federal policy shift is prompting Medtronic to put its Responsive Orthopedics business on the auction block. The May 2016 acquisition of Minneapolis-based Responsive for an undisclosed amount put Medtronic in line for a bundled joint replacement program piloted…

March282019March282019

A NEW RF SYSTEM: VENCLOSE 2ND GENERATION RADIOFREQUENCY TECHNOLOGY OUTPERFORMS LEGACY SYSTEM

By Larry Storer The great medical technology companies of our time start and develop in a variety of ways. Some start with a product or idea and built a market around it. Some start as spinoffs from existing…

FDA evaluating stents, balloons with paclitaxel coating following JAHA evaluation

A December study in The Journal of the American Heart Association by Konstantinos Katsanos, MD, of Rion, Greece, et al, reported a higher risk of death after balloons and stents used to open vessels in the legs were coated with…

MEDTRONIC GETS OK TO STUDY PATIENTS WITH BICUSPID AORTIC VALUES USING COREVALVE EVOLUT TAVR SYSTEM

The U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) for Medtronic to initiate a single-arm study to evaluate the CoreValve Evolut TAVR system in patients with bicuspid aortic valves who are at low risk of…

January32019

IN.PACT ADMIRAL: MEDTRONIC SHARES FIVE-YEAR DRUG-COATED BALLOON DATA

Medtronic plc data presented Nov. 12 reinforce the durability, safety, and effectiveness of the IN.PACT Admiral drug-coated balloon (DCB) in patients with peripheral artery disease in the superficial femoral and popliteal arteries. The five-year and final results from the…